Q2 2014

Filed Jan 8, 2015 · 10-Q · 192 days after period end · 0001513160-15-000010

Q2 2014 · 10-Q

Revenue

$25.00K

−86.3% vs Q2 2013

Net Income

-$262.00K

N/M vs Q2 2013

EPS Diluted

$0.00

— vs Q2 2013

Gross Profit$8,000−86.7%

Operating Income

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$25.00K	$183.00K	$1.00K	$1.00K
Net Income	-$262.00K	-$319.00K	-$2.40M	-$662.00K
EPS Diluted	$0.00	$0.00	-$0.01	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR